Introduction: When to Consider Diagnostic Evaluation
If you have been diagnosed with marginal zone lymphoma in the past and notice changes in your health, it may be time to speak with your doctor about further testing. Relapsed marginal zone lymphoma refers to the disease that comes back after a period when it seemed to be gone or under control. Refractory disease describes lymphoma that does not respond to treatment, meaning the cancer cells continue to grow, or when the positive effects of treatment do not last long.[1][2]
People who develop new symptoms such as swollen lymph nodes, persistent tiredness, unexplained weight loss, fevers, or night sweats should contact their healthcare team. Sometimes, patients may feel generally unwell or notice lumps under the skin in areas like the neck, underarms, or groin. These signs do not always mean the lymphoma has returned, but they are important reasons to schedule an appointment.[3]
In some cases, lymphoma may be discovered during routine follow-up visits through blood tests or scans, even before symptoms appear. This is especially true for patients who are being monitored after initial treatment. Regular check-ups help doctors catch any changes early, which can be important for planning next steps.[2]
Diagnostic Methods for Identifying and Distinguishing the Disease
When doctors suspect that marginal zone lymphoma has relapsed or is not responding to treatment, they use a variety of tests to confirm the diagnosis and understand how far the disease has spread. These diagnostic methods help distinguish lymphoma from other illnesses and provide a clear picture of what is happening inside the body.[3]
Physical Examination
The diagnostic process often begins with a thorough physical examination. Your doctor will feel for swollen lymph nodes in areas such as the neck, underarms, and groin. They will also check whether your spleen is enlarged, as this organ can become affected in certain types of marginal zone lymphoma. The physical exam helps guide the doctor toward which additional tests might be needed.[3]
Blood Tests
Blood tests are a common and important tool in diagnosing relapsed or refractory marginal zone lymphoma. These tests can sometimes reveal the presence of lymphoma cells circulating in the blood. Blood tests are also used to check for infections that may increase the risk of marginal zone lymphoma or influence its behavior, such as hepatitis C virus infection.[3]
Additionally, routine blood work can assess your overall health, including how well your kidneys and liver are functioning, and whether your blood counts are normal. Abnormal blood counts may suggest that the bone marrow is affected by lymphoma.[3]
Imaging Tests
Imaging tests create pictures of the inside of your body and are crucial for understanding where the lymphoma is located and how much it has spread. Several types of imaging may be used, depending on your specific situation.[3]
Computed tomography (CT) scans use X-rays and computer technology to produce detailed cross-sectional images of organs, lymph nodes, and other tissues. CT scans can show whether lymph nodes are enlarged or if the lymphoma has spread to other parts of the body.[3]
Magnetic resonance imaging (MRI) uses powerful magnets and radio waves to create detailed images of soft tissues. MRI scans may be used when more detailed pictures are needed, especially for areas that are difficult to see with other imaging methods.[3]
Ultrasound uses sound waves to create pictures of organs and structures inside the body. It is commonly used to examine the abdomen, including the spleen and liver, and to look at enlarged lymph nodes.[3]
Positron emission tomography (PET) scans involve injecting a small amount of radioactive sugar into the body. Cancer cells, which are more active than normal cells, absorb more of this sugar and show up as bright spots on the scan. PET scans are useful for detecting active lymphoma and assessing how well treatment is working.[3]
Lymph Node Biopsy
A biopsy is a procedure where a sample of tissue is removed and examined under a microscope. A lymph node biopsy is one of the most definitive ways to diagnose marginal zone lymphoma and confirm whether it has relapsed or become refractory.[3]
There are different types of biopsies. An excisional biopsy removes an entire lymph node, while an incisional biopsy removes only part of a lymph node. The tissue sample is sent to a laboratory, where specialists examine the cells to determine if lymphoma is present and identify its specific characteristics.[3]
The biopsy helps doctors understand the type of marginal zone lymphoma you have and whether it has changed over time. Sometimes, lymphoma cells can transform into a more aggressive form, which may require different treatment approaches.[4]
Bone Marrow Aspiration and Biopsy
Bone marrow aspiration and biopsy are procedures used to collect samples of bone marrow, the soft tissue inside bones where blood cells are made. The bone marrow has both a solid part and a liquid part. During aspiration, a needle is used to draw out a sample of the liquid part. During biopsy, a needle collects a small piece of the solid tissue. These samples are usually taken from the hip bone.[3]
The samples are examined in a laboratory to see if lymphoma cells are present in the bone marrow. This information is important for understanding the extent of the disease and planning treatment. In marginal zone lymphoma, bone marrow involvement may affect prognosis and treatment decisions.[3]
Endoscopy
An endoscopy is a procedure that allows doctors to look inside certain parts of your body using a thin, flexible tube with a light and camera at the end. For marginal zone lymphoma, an upper endoscopy may be performed to examine the esophagus (the tube that carries food from your mouth to your stomach), the stomach, and the first part of the small intestine.[3]
This test is particularly important for gastric marginal zone lymphoma, which often develops in the stomach. During the endoscopy, the doctor can take small tissue samples (biopsies) from any abnormal areas to check for lymphoma cells.[3]
In some cases, endoscopy may also be used to look at other organs depending on where the lymphoma is suspected to be. The procedure is usually done under sedation, so you are comfortable and relaxed.[3]
Diagnostics for Clinical Trial Qualification
Clinical trials are research studies that test new treatments or combinations of treatments for diseases like marginal zone lymphoma. If you are considering joining a clinical trial, your doctor will need to perform specific diagnostic tests to determine if you are eligible. These tests ensure that the trial is suitable for your particular condition and that you meet the criteria set by the researchers.[1]
The exact tests required for clinical trial qualification vary depending on the trial’s design and the treatment being studied. However, there are some common diagnostic procedures that are frequently used to assess eligibility for trials focused on relapsed or refractory marginal zone lymphoma.[1]
Confirming Relapsed or Refractory Status
One of the first steps in qualifying for a clinical trial is confirming that your marginal zone lymphoma has relapsed or is refractory. This typically involves repeating many of the diagnostic tests mentioned earlier, such as imaging scans, biopsies, and blood tests. The results help establish that the disease has returned after treatment or that it did not respond adequately to previous therapies.[1][2]
Doctors will also review your medical history and previous treatment records to understand how your lymphoma has behaved over time. This information is important for matching you to a trial that is testing therapies appropriate for your stage and type of disease.[1]
Assessing Overall Health and Organ Function
Clinical trials often require that participants are healthy enough to tolerate the experimental treatments being tested. To assess your overall health, doctors will perform a series of tests to evaluate how well your organs are functioning.[3]
Blood tests are used to check your kidney and liver function, as these organs play a key role in processing medications. Abnormal kidney or liver function may affect your eligibility for certain trials, especially those testing drugs that are cleared from the body through these organs.[3]
Your blood counts will also be checked to ensure that your bone marrow is producing enough red blood cells, white blood cells, and platelets. Low blood counts may indicate that the bone marrow is affected by lymphoma or previous treatments, which could influence trial eligibility.[3]
Imaging and Disease Extent
Clinical trials may require specific imaging tests to determine the extent of your disease before you can enroll. CT scans, PET scans, or other imaging studies may be performed to measure the size and number of lymphoma lesions in your body. These baseline measurements are important because they allow researchers to track how well the treatment is working over time.[3]
Some trials have specific criteria regarding disease burden, meaning they may only accept patients whose lymphoma has spread to certain areas or reached a certain size. The imaging results help determine if you meet these criteria.[1]
Tissue Samples and Biomarker Testing
In some clinical trials, especially those testing targeted therapies, researchers may need to analyze tissue samples from your lymphoma to look for specific biomarkers. Biomarkers are molecules or genetic changes in the cancer cells that can predict how the disease will respond to certain treatments.[1]
A fresh biopsy may be required to obtain tissue for biomarker testing, even if you have had a biopsy in the past. This is because the characteristics of lymphoma cells can change over time, and having up-to-date information is critical for selecting the right treatment approach.[4]
Examples of biomarker testing might include looking for genetic mutations or checking the expression of certain proteins on the surface of lymphoma cells. These tests help researchers understand which patients are most likely to benefit from the experimental treatment being studied.[4]
Additional Tests Based on Trial Requirements
Depending on the specific clinical trial, additional tests may be required. For example, some trials may ask for an electrocardiogram (ECG) to check your heart’s electrical activity, especially if the treatment being tested could affect heart function. Others may require pulmonary function tests to assess lung capacity if the treatment could impact breathing.[3]
Your doctor and the clinical trial team will explain all the tests you need to complete before enrolling. These tests ensure that the trial is safe for you and that the researchers can accurately measure the treatment’s effects.[1]
